Table 3.
Inpatient admissions, renal outcomes, and follow-up data.
| N (%) | Median number of months (IQR) | ||
|---|---|---|---|
| Outcomes | Inpatient admission | 40 (61) | |
| Number of inpatient admissions | |||
| 0 | 26 (39) | ||
| 1 | 22 (33) | ||
| 2 | 7 (11) | ||
| 3 | 2 (3) | ||
| 4 | 9 (14) | ||
| First inpatient admission age | 4.9 (1.2, 6.4) | ||
| Length of stay | 0.33 (0.13, 0.5) | ||
| CKD/eGFR at time of last visit* | |||
| Stage 1: ≥90 mL/min/1.73 m2 | 43 (70) | ||
| Stage 2: 60–89 mL/min/1.73 m2 | 16 (26) | ||
| Stage 3: 30–59 mL/min/1.73 m2 | 1 (2) | ||
| Stage 4: 15–29 mL/min/1.73 m2 | 0 (0) | ||
| Stage 5: <15 mL/min/1.73 m2 | 1 (2) | ||
| Follow-up | Age in months at time of last visit | 72.3 (40.9, 137.2) | |
| Renal ultrasound findings | |||
| Hydronephrosis | 12 (18) | ||
| Bladder distension/trabeculation | 5 (8) | ||
| Renal dysplasia | 9 (14) | ||
| Enuresis at last visit | 29 (44) | ||
| Dialysis | 1 (2) | ||
| Age in months at first dialysis | 13 |
*
Values available for 61 subjects.